Emma Reeve
Director at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 6SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 73410,666 held (−6%) | $76.00 | $56K | -14.9% |
| Dec 5SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7336,666 held (−10%) | $78.62 | $58K | -17.7% |
| Nov 25SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10,0006,666 held (−60%) | $79.50 | $795K | -18.6% |
| Nov 14SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 7,3336,666 held (−52%) | $74.50 | $546K | -13.2% |
| Oct 31SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,6666,666 held (−35%) | $69.50 | $255K | -6.9% |
| Oct 31SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 12,0006,666 held (−64%) | $69.50 | $834K | -6.9% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,02817,304 held (−15%) | $65.09 | $197K | -0.6% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,59112,713 held (−27%) | $66.09 | $303K | -2.1% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,38110,332 held (−19%) | $66.87 | $159K | -3.2% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,16315,081 held (−13%) | $65.02 | $141K | -0.5% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,14911,932 held (−21%) | $66.11 | $208K | -2.1% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,60010,332 held (−13%) | $66.93 | $107K | -3.3% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,72916,253 held (−14%) | $65.05 | $178K | -0.5% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,03712,216 held (−25%) | $66.10 | $267K | -2.1% |
| Oct 7SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,88410,332 held (−15%) | $66.89 | $126K | -3.3% |
- Sell
Director Emma Reeve sold $56K of PTCT at $76.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emma Reeve sold $58K of PTCT at $78.62 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Emma Reeve sold $795K of PTCT at $79.50 — cuts the stake by 60%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Emma Reeve sold $546K of PTCT at $74.50 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Emma Reeve sold $255K of PTCT at $69.50 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Emma Reeve sold $834K of PTCT at $69.50 — cuts the stake by 64%; pre-scheduled 10b5-1 plan sale.